Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention — Stella

View on ClinicalTrials.gov

Recruiting

Back to ECMO trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Beijing Anzhen Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Beijing Anzhen Hospital

Collaborators

Wuhan Asia Heart Hospital, The First Hospital of Jilin University

Enrollment target

~176 participants

Started

March 2025

Primary completion

November 2026

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.